Loading…
Based on limited metadata, Black Moon Enterprises, Inc. received an FDA Warning Letter on February 9, 2018, regarding a product classified as "Other," though the specific product category and nature of the violations are not detailed in the available information. Without access to the full warning letter text or subject line details, the exact regulatory concerns and violations cannot be specified. The issuing office information is also unavailable, which would typically indicate which FDA division oversaw the inspection. To understand the specific compliance issues and required corrective actions, the complete warning letter would need to be reviewed.